HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute Interstitial Pneumonia (Hamman-Rich Syndrome) in Lung Transplantation: A Case Series.

AbstractBACKGROUND:
Acute interstitial pneumonia (AIP), also known as Hamman-Rich syndrome, is a rare and rapidly progressive idiopathic interstitial lung disease with a high mortality rate. Treatment is limited to supportive care and empirical high-dose steroids; however, outcomes are generally poor. There are few reports of lung transplantation (LTx) in patients with AIP.
METHODS:
We retrospectively identified patients with AIP among those who underwent LTx at our center between January 2008 and December 2020.
RESULTS:
During the study period, 4 patients with AIP underwent bilateral LTx: 3 men and 1 woman, between 30 and 57 years of age. The lung allocation score ranged between 71 and 89. Of the 4 patients, 2 needed extracorporeal membrane oxygenation and mechanical ventilation (MV) and 1 needed MV preoperatively. Time of onset to transplant ranged from 1 to 3 months. None of the patients had primary graft dysfunction after LTx; 2 had acute cellular rejection and 1 had chronic lung allograft dysfunction. The 4 patients are alive with survival ranging between 1 and 12 years after LTx.
CONCLUSION:
AIP should be considered in patients with acute respiratory failure without a clear etiology. Our study showed that LTx led to good outcomes and should be considered as a treatment option in appropriate candidates.
AuthorsHailey M Shepherd, Yuriko Terada, Tsuyoshi Takahashi, Michael K Pasque, Hrishikesh S Kulkarni, Rodrigo Vazquez Guillamet, Chad A Witt, Ruben G Nava, Varun Puri, Daniel Kreisel, G Alexander Patterson, Ramsey R Hachem
JournalTransplantation proceedings (Transplant Proc) Vol. 54 Issue 8 Pg. 2313-2316 (Oct 2022) ISSN: 1873-2623 [Electronic] United States
PMID36075742 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Elsevier Inc. All rights reserved.
Topics
  • Male
  • Female
  • Humans
  • Hamman-Rich Syndrome
  • Retrospective Studies
  • Lung Transplantation (adverse effects)
  • Idiopathic Interstitial Pneumonias (diagnosis, surgery)
  • Extracorporeal Membrane Oxygenation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: